Sage Journals: Discover world-class research

Abstract

The cluster randomized crossover design has been proposed to improve efficiency over the traditional parallel-arm cluster randomized design. While statistical methods have been developed for designing cluster randomized crossover trials, they have exclusively focused on testing the overall average treatment effect, with little attention to differential treatment effects across subpopulations. Recently, interest has grown in understanding whether treatment effects may vary across pre-specified patient subpopulations, such as those defined by demographic or clinical characteristics. In this article, we consider the two-treatment two-period cluster randomized crossover design under either a cross-sectional or closed-cohort sampling scheme, where it is of interest to detect the heterogeneity of treatment effect via an interaction test. Assuming a patterned correlation structure for both the covariate and the outcome, we derive new sample size formulas for testing the heterogeneity of treatment effect with continuous outcomes based on linear mixed models. Our formulas also address unequal cluster sizes and therefore allow us to analytically assess the impact of unequal cluster sizes on the power of the interaction test in cluster randomized crossover designs. We conduct simulations to confirm the accuracy of the proposed methods, and illustrate their application in two real cluster randomized crossover trials.

Keywords

Cluster randomized crossover trials heterogeneous treatment effect interaction test sample size formula treatment effect moderation variable cluster sizes

Get full access to this article

View all access options for this article.

References

Weinfurt

Hernandez

Coronado

et al. Pragmatic clinical trials embedded in healthcare systems: generalizable lessons from the NIH collaboratory. BMC Med Res Methodol 2017; 17: 1–10.

Murray

. Design and analysis of group-randomized trials. 29, USA: Oxford University Press, 1998.

Turner

Gallis

et al. Review of recent methodological developments in group-randomized trials: part 1—design. Am J Public Health 2017; 107: 907–915.

Turner

White

Croudace

. Analysis of cluster randomized cross-over trial data: a comparison of methods. Stat Med 2007; 26: 274–289.

Arnup

McKenzie

Hemming

et al. Understanding the cluster randomised crossover design: a graphical illustration of the components of variation and a sample size tutorial. Trials 2017; 18: 1–15.

Giraudeau

Ravaud

Donner

. Sample size calculation for cluster randomized cross-over trials. Stat Med 2008; 27: 5578–5585.

Forbes

Akram

Pilcher

et al. Cluster randomised crossover trials with binary data and unbalanced cluster sizes: application to studies of near-universal interventions in intensive care. Clinical Trials 2015; 12: 34–44.

Forbes

Turner

et al. Power and sample size requirements for GEE analyses of cluster randomized crossover trials. Stat Med 2019; 38: 636–649.

Nicholls

Carroll

Nix

et al. Ethical considerations within pragmatic randomized controlled trials in dementia: results from a literature survey. Alzheimer’s & Dementia: Translational Research & Clinical Interventions 2022; 8: e12287.

10.

Kravitz

Duan

Braslow

. Evidence-based medicine, heterogeneity of treatment effects, and the trouble with averages. Milbank Q 2004; 82: 661–687.

11.

Yang

Starks

et al. Sample size requirements for detecting treatment effect heterogeneity in cluster randomized trials. Stat Med 2020; 39: 4218–4237.

12.

Tong

Esserman

. Accounting for unequal cluster sizes in designing cluster randomized trials to detect treatment effect heterogeneity. Stat Med 2022; 41: 1376–1396.

13.

Chen

Tian

et al. Designing three-level cluster randomized trials to assess treatment effect heterogeneity. Biostatistics 2023; 24: 833–849.

14.

Chen

Tian

et al. Planning stepped wedge cluster randomized trials to detect treatment effect heterogeneity. Stat Med 2024; 43: 890–911.

15.

Tong

Taljaard

. Sample size considerations for assessing treatment effect heterogeneity in randomized trials with heterogeneous intracluster correlations and variances. Stat Med 2023; 42: 3392–3412.

16.

Spybrook

Kelcey

Dong

. Power for detecting treatment by moderator effects in two-and three-level cluster randomized trials. J Educ Behav Stat 2016; 41: 605–627.

17.

Dong

Kelcey

Spybrook

. Power analyses for moderator effects in three-level cluster randomized trials. The Journal of Experimental Education 2018; 86: 489–514.

18.

Rietbergen

Moerbeek

. The design of cluster randomized crossover trials. J Educ Behav Stat 2011; 36: 472–490.

19.

Teerenstra

Preisser

et al. Sample size considerations for GEE analyses of three-level cluster randomized trials. Biometrics 2010; 66: 1230–1237.

20.

Wang

Turner

Preisser

et al. Power considerations for generalized estimating equations analyses of four-level cluster randomized trials. Biometrical J 2022; 64: 663–680.

21.

Redden

. Small sample performance of bias-corrected sandwich estimators for cluster-randomized trials with binary outcomes. Stat Med 2015; 34: 281–296.

22.

Wang

Lagakos

Ware

et al. Statistics in medicine—reporting of subgroup analyses in clinical trials. New Engl J Med 2007; 357: 2189–2194.

23.

Wang

Ware

. Detecting moderator effects using subgroup analyses. Prev Sci 2013; 14: 111–120.

24.

Turner

Preisser

. Sample size determination for GEE analyses of stepped wedge cluster randomized trials. Biometrics 2018; 74: 1450–1458.

25.

Morris

White

Crowther

. Using simulation studies to evaluate statistical methods. Stat Med 2019; 38: 2074–2102.

26.

Korevaar

Kasza

Taljaard

et al. Intra-cluster correlations from the CLustered OUtcome Dataset bank to inform the design of longitudinal cluster trials. Clinical Trials 2021; 18: 529–540.

27.

Wang

Schmicker

Daya

et al. Effect of a strategy of initial laryngeal tube insertion vs endotracheal intubation on 72-hour survival in adults with out-of-hospital cardiac arrest: a randomized clinical trial. Jama 2018; 320: 769–778.

28.

Wallach

Sullivan

Trepanowski

et al. Sex based subgroup differences in randomized controlled trials: empirical evidence from cochrane meta-analyses. bmj 2016; 355.

29.

Landrigan

Rahman

Sullivan

et al. Effect on patient safety of a resident physician schedule without 24-hour shifts. New England J Med 2020; 382: 2514–2523.

30.

Blackwell

Kriesel

Vittinghoff

et al. Design and recruitment of the randomized order safety trial evaluating resident-physician schedules (ROSTERS) study. Contemp Clin Trials 2019; 80: 22–33.

31.

Starks

Sanders

Coeytaux

et al. Assessing heterogeneity of treatment effect analyses in health-related cluster randomized trials: a systematic review. PLoS ONE 2019; 14: e0219894.

32.

Copas

Lewis

Thompson

et al. Designing a stepped wedge trial: three main designs, carry-over effects and randomisation approaches. Trials 2015; 16: 1–12.

33.

Wang

Goldfeld

Taljaard

et al. Sample size requirements to test subgroup-specific treatment effects in cluster-randomized trials. Prev Sci 2023; 1–15.

34.

Morgan

Forbes

Keogh

et al. Choosing appropriate analysis methods for cluster randomised cross-over trials with a binary outcome. Stat Med 2017; 36: 318–333.

35.

Maleyeff

Wang

Haneuse

et al. Sample size requirements for testing treatment effect heterogeneity in cluster randomized trials with binary outcomes. Stat Med 2023; 42: 5054–5083.

36.

Ouyang

Hemming

et al. Estimating intra-cluster correlation coefficients for planning longitudinal cluster randomized trials: a tutorial. Int J Epidemiol 2023; 52: 1634–1647.

37.

Ryan

Esserman

. Maximin optimal cluster randomized designs for assessing treatment effect heterogeneity. Stat Med 2023; 42: 3764–3785.

Supplementary Material

Please find the following supplemental material available below.

For Open Access articles published under a Creative Commons License, all supplemental material carries the same license as the article it is associated with.

For non-Open Access articles published, all supplemental material carries a non-exclusive license, and permission requests for re-use of supplemental material or any part of supplemental material shall be sent directly to the copyright owner as specified in the copyright notice associated with the article.

0.00 MB

0.48 MB

Sample size and power calculation for testing treatment effect heterogeneity in cluster randomized crossover designs

Abstract

Keywords

Get full access to this article

References

Supplementary Material